April 25th 2024
A recent study revealed a significant increase in intrauterine device usage among reproductive-aged women in South Carolina following the implementation of the Choose Well initiative.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 11, 2024
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Study finds copper IUD and LNG-IUS can impact microbiota over time
November 12th 2020Neither the levonorgestrel-releasing intrauterine system (LNG-IUS) nor the copper intrauterine device (IUD) impact the incidence of cellular atypia, but do interfere with the microbiota over time, according to liquid-based cervical cytology and microbiological analyses.
Read More
Contraception lessons for 2020
October 29th 2020“Telehealth visits serve to ensure patient-centered, shared decision-making counseling, as well as allowing the provider to confirm that the patients are good candidates with no contraindications for their method of choice,” Eve Espey, MD, MPH, said.
Read More
Postpartum etonogestrel-releasing implants and depression
June 24th 2020Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.
Read More
Study finds plasma oxytocin levels higher in OC users
June 10th 2020Plasma oxytocin levels are significantly higher in oral contraceptive (OC) users than in to non-users, according to a study in Scientific Reports. The cross-sectional study of nearly 200 women also found that scores for satisfaction with life were higher among OC users.
Read More
Attitudes about contraception in postpartum women with pregestational diabetes
February 11th 2020Women with pregestational diabetes mellitus (DM) who recognize benefits in contraception and preconception care are much more likely to use contraception postpartum, according to a survey in the Journal of Obstetrics, Gynecologic & Neonatal Nursing.
Read More
Effectiveness of contraceptive counseling strategies
January 8th 2020Counseling strategies that target women initiating a contraception method, including structured counseling on side effects, tend to increase contraceptive continuation, according to research from BMJ Sexual & Reproductive Health.
Read More
Follow-up care and continuation rates for long-acting reversible contraceptives
November 7th 2019Continuation rates for long-acting reversible contraceptives (LARC) were high in a group of adolescent and young adult (AYA) women, according to a retrospective chart review in the Journal of Pediatric and Adolescent Gynecology.
Read More
Oral contraceptives and concurrent depressive symptoms
November 7th 2019A JAMA Psychiatry prospective cohort study found that scores for depression were higher among younger adolescents who used oral contraceptives (OCs) than those who did not, but the connection did not remain when all included age groups of the study were combined.
Read More
Progestin-only contraceptives and sexual function among first-time users
October 24th 2019A recent presentation at the 2019 American Society for Reproductive Medicine Scientific Congress & Expo compared female sexual function (FSF) in three progestin-only contraceptives (POCs) among first-time users.
Read More